目录:MedChemExpress LLC>>生化试剂>> 1400W Dihydrochloride | MCE
CAS | 214358-33-5 | 纯度 | 99.94% |
---|---|---|---|
分子量 | 250.17 | 分子式 | C₁₀H₁₇Cl₂N₃ |
供货周期 | 现货 | 规格 | 5 mg |
货号 | HY-18731 | 应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 214358-33-5
产品活性:1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
研究领域:Immunology/Inflammation
作用靶点:NO Synthase
In Vitro: 1400W is a slow, tight binding inhibitor of human inducible nitric- oxide synthase (iNOS). The slow onset of inhibition by 1400W shows saturation kinetics with a maximal rate constant of 0.028 s-1 and a binding constant of 2.0 μM. Inhibition is dependent on the cofactor NADPH. 1400W is at least 5000-fold selective for iNOS versus eNOS. In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) is relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 μM and 50 μM, respectively. 1400W treatment inhibits iNOS expression without affecting nNOS or eNOS. 1400W also reduces NO, 3-NT and MDA production, and prevents neuronal cell apoptosis in cerebral cortex.
In Vivo: 1400W potently (ED50=0.3 mg/kg) reduces the delayed vascular injury in rats attributable to LPS-induced iNOS but fails to exacerbate acute vascular leakage when given concurrently with LPS. Administration of 1400W lowers NOx levels in all the experimental groups. In addition, lipid peroxidation, the percentage of apoptotic cells, and nitrated protein expression fall in the late post-hypoxia period (48 h and 5 days).
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Neuroprotective Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Human Metabolite Library | Mitochondrial Protection Compound Library | Membrane Protein-targeted Compound Library | Palmitoylglycine | Ermanin | Cistanoside A | Mifepristone-13C,d3 | Dehydroevodiamine hydrochloride | Chondroitin sulfate | N'-Nitro-D-arginine | Banoxantrone | Crocin II | L-NIL hydrochloride | L-Arginine-d7 (hydrochloride) | Ethyl 3,4-dihydroxybenzoate | 2-Thiouracil-13C,15N2 | NOS-IN-3 | 3-Bromo-7-nitroindazole | Ethyl Caffeate | Beclometasone dipropionate | Carboxyebselen | (-)-10,11-Dihydroxyfarnesol | Cauloside C | Mifepristone-d3 | Atraric acid | Chloranthalactone E | Dimaprit dihydrochloride | Britannilactone diacetate | 2-Iminobiotin | Inflexuside A | TP508 | AVE3085 | Dimethoxycurcumin
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种*仅有化合物库,我们致力于为*科研客户提供前沿的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果;
• 专业团队跟踪新的制药及生命科学研究进展,为您提供*新的活性化合物;
• 与世界各大制药公司及*科研机构建立了长期的合作。